HUP9904408A2 - Lactobacillus vakcina prosztatagyulladás és jóindulatú prostatahyperplasia kezelésére - Google Patents

Lactobacillus vakcina prosztatagyulladás és jóindulatú prostatahyperplasia kezelésére

Info

Publication number
HUP9904408A2
HUP9904408A2 HU9904408A HUP9904408A HUP9904408A2 HU P9904408 A2 HUP9904408 A2 HU P9904408A2 HU 9904408 A HU9904408 A HU 9904408A HU P9904408 A HUP9904408 A HU P9904408A HU P9904408 A2 HUP9904408 A2 HU P9904408A2
Authority
HU
Hungary
Prior art keywords
prostata
inflammatory
treating
hyperplasia
benign
Prior art date
Application number
HU9904408A
Other languages
English (en)
Inventor
József Bartus
Erika Lázár
Gyula Varga
Károly Újhelyi
Original Assignee
József Bartus
Erika Lázár
Gyula Varga
Károly Újhelyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by József Bartus, Erika Lázár, Gyula Varga, Károly Újhelyi filed Critical József Bartus
Priority to HU9904408A priority Critical patent/HU227086B1/hu
Publication of HUP9904408D0 publication Critical patent/HUP9904408D0/hu
Priority to DE60044539T priority patent/DE60044539D1/de
Priority to YUP-374/02A priority patent/RS51201B/sr
Priority to PCT/HU2000/000122 priority patent/WO2001037862A2/en
Priority to CA2394843A priority patent/CA2394843C/en
Priority to AU18741/01A priority patent/AU779214B2/en
Priority to EP00981507A priority patent/EP1272216B1/en
Priority to ROA200200663A priority patent/RO122760B1/ro
Priority to AT00981507T priority patent/ATE470452T1/de
Priority to SI200020063A priority patent/SI20960B/sl
Priority to ES00981507T priority patent/ES2348591T3/es
Priority to PL355886A priority patent/PL201804B1/pl
Priority to PT00981507T priority patent/PT1272216E/pt
Priority to CZ20021771A priority patent/CZ302662B6/cs
Priority to DK00981507.7T priority patent/DK1272216T3/da
Priority to SK738-2002A priority patent/SK288132B6/sk
Priority to UA2002064624A priority patent/UA78673C2/uk
Priority to IL14977900A priority patent/IL149779A0/xx
Priority to EA200200602A priority patent/EA005198B1/ru
Publication of HUP9904408A2 publication Critical patent/HUP9904408A2/hu
Priority to IL149779A priority patent/IL149779A/en
Priority to US12/077,780 priority patent/US20080175865A1/en
Publication of HU227086B1 publication Critical patent/HU227086B1/hu
Priority to US13/049,344 priority patent/US9056073B2/en
Priority to US14/735,637 priority patent/US20160051657A1/en
Priority to US15/891,620 priority patent/US20180161414A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány prosztatagyulladás és jóindulatú prostatahyperplasia (I-II. stádium) kezelésére szolgáló vakcinára vonatkozik, amely avakcinagyártásban szokásos vivőanyagok és/vagy egyéb segédanyagokmellett laktobacillusokat tartalmaz elölt állapotban. Ó
HU9904408A 1999-11-25 1999-11-25 Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia HU227086B1 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
HU9904408A HU227086B1 (en) 1999-11-25 1999-11-25 Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
EA200200602A EA005198B1 (ru) 1999-11-25 2000-11-23 Вакцина для лечения воспаления и доброкачественной гиперплазии предстательной железы на основе бактерий lactobacilli и способ лечения указанных заболеваний
PT00981507T PT1272216E (pt) 1999-11-25 2000-11-23 Vacina compreendendo lactobacilos para o tratamento da inflamação da próstata e de hiperplasias benignas da próstata
DK00981507.7T DK1272216T3 (da) 1999-11-25 2000-11-23 Vaccine, der omfatter lactobacilli til behandling af betændelse i prostata og godartet prostatahyperplasi
PCT/HU2000/000122 WO2001037862A2 (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
CA2394843A CA2394843C (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacillus strains for treating prostate inflammation and benign prostate hyperplasias
AU18741/01A AU779214B2 (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
EP00981507A EP1272216B1 (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
ROA200200663A RO122760B1 (ro) 1999-11-25 2000-11-23 Vaccin pentru tratarea inflamaţiei prostatei şi a hiperplaziilor benigne de prostată, şi utilizarea lactobacililor
AT00981507T ATE470452T1 (de) 1999-11-25 2000-11-23 Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien
SI200020063A SI20960B (sl) 1999-11-25 2000-11-23 Vakcina, ki obsega seve lactobacillus-a, za zdravljenje ventja prostate in benigne hiperplazije prostate
ES00981507T ES2348591T3 (es) 1999-11-25 2000-11-23 Una vacuna que comprende lactobacilos para tratar la inflamación de prostata e hiperplasisas prostaticas benignas.
PL355886A PL201804B1 (pl) 1999-11-25 2000-11-23 Zastosowanie szczepów Lactobacillus
DE60044539T DE60044539D1 (de) 1999-11-25 2000-11-23 Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien
CZ20021771A CZ302662B6 (cs) 1999-11-25 2000-11-23 Kmeny rodu Lactobacillus pro použití v lécbe zánetu prostaty a benigních hyperplazií prostaty
YUP-374/02A RS51201B (sr) 1999-11-25 2000-11-23 Vakcina koja obuhvata sojeve lactobacillus za lečenje upale prostate i benigne prostatne hiperplazije
SK738-2002A SK288132B6 (sk) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
UA2002064624A UA78673C2 (en) 1999-11-25 2000-11-23 Use of lactobacillus strains for treating prostate inflammation and benign prostate hyperplasias
IL14977900A IL149779A0 (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
IL149779A IL149779A (en) 1999-11-25 2002-05-21 Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias and its production
US12/077,780 US20080175865A1 (en) 1999-11-25 2008-03-21 Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
US13/049,344 US9056073B2 (en) 1999-11-25 2011-03-16 Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
US14/735,637 US20160051657A1 (en) 1999-11-25 2015-06-10 Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
US15/891,620 US20180161414A1 (en) 1999-11-25 2018-02-08 Vaccine comprising lactobacillus strains for treating prostate inflammation and benign prostate hyperplasias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9904408A HU227086B1 (en) 1999-11-25 1999-11-25 Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia

Publications (3)

Publication Number Publication Date
HUP9904408D0 HUP9904408D0 (en) 2000-01-28
HUP9904408A2 true HUP9904408A2 (hu) 2002-03-28
HU227086B1 HU227086B1 (en) 2010-06-28

Family

ID=90014600

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904408A HU227086B1 (en) 1999-11-25 1999-11-25 Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia

Country Status (20)

Country Link
US (4) US20080175865A1 (hu)
EP (1) EP1272216B1 (hu)
AT (1) ATE470452T1 (hu)
AU (1) AU779214B2 (hu)
CA (1) CA2394843C (hu)
CZ (1) CZ302662B6 (hu)
DE (1) DE60044539D1 (hu)
DK (1) DK1272216T3 (hu)
EA (1) EA005198B1 (hu)
ES (1) ES2348591T3 (hu)
HU (1) HU227086B1 (hu)
IL (2) IL149779A0 (hu)
PL (1) PL201804B1 (hu)
PT (1) PT1272216E (hu)
RO (1) RO122760B1 (hu)
RS (1) RS51201B (hu)
SI (1) SI20960B (hu)
SK (1) SK288132B6 (hu)
UA (1) UA78673C2 (hu)
WO (1) WO2001037862A2 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723965A1 (en) * 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
HUP0700552A2 (en) 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation
EP3630130B1 (en) 2017-06-02 2022-08-31 Arizona Board of Regents on behalf of Arizona State University A method to create personalized cancer vaccines
WO2019055618A1 (en) 2017-09-15 2019-03-21 Arizona Board Of Regents On Behalf Of Arizona State University METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639280A5 (de) * 1977-12-23 1983-11-15 Solco Basel Ag Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
DE19522472C2 (de) * 1995-06-21 1998-07-02 Eugen Baumgaertner Herstellungsverfahren eines Fermentationsproduktes zur Behandlung von Prostataleiden
KR100406344B1 (ko) * 1997-08-21 2003-11-19 뉴질랜드 대어리 보오드 면역을 향상시키는 젖산균
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

Also Published As

Publication number Publication date
WO2001037862A3 (en) 2001-11-22
SI20960A (sl) 2003-02-28
PL355886A1 (en) 2004-05-31
US20180161414A1 (en) 2018-06-14
US20160051657A1 (en) 2016-02-25
IL149779A (en) 2009-05-04
ES2348591T3 (es) 2010-12-09
RS51201B (sr) 2010-12-31
US20080175865A1 (en) 2008-07-24
SI20960B (sl) 2011-01-31
PL201804B1 (pl) 2009-05-29
EA200200602A1 (ru) 2002-10-31
IL149779A0 (en) 2002-11-10
DK1272216T3 (da) 2010-09-27
HU227086B1 (en) 2010-06-28
EP1272216B1 (en) 2010-06-09
HUP9904408D0 (en) 2000-01-28
SK7382002A3 (en) 2002-11-06
PT1272216E (pt) 2010-09-14
ATE470452T1 (de) 2010-06-15
UA78673C2 (en) 2007-04-25
CA2394843A1 (en) 2001-05-31
YU37402A (sh) 2005-06-10
CZ302662B6 (cs) 2011-08-24
WO2001037862A2 (en) 2001-05-31
CZ20021771A3 (cs) 2002-11-13
RO122760B1 (ro) 2010-01-29
DE60044539D1 (de) 2010-07-22
EA005198B1 (ru) 2004-12-30
US20110243990A1 (en) 2011-10-06
AU1874101A (en) 2001-06-04
AU779214B2 (en) 2005-01-13
EP1272216A2 (en) 2003-01-08
CA2394843C (en) 2011-01-18
US9056073B2 (en) 2015-06-16
SK288132B6 (sk) 2013-10-02

Similar Documents

Publication Publication Date Title
NO20013554L (no) Antikonvulsive derivater som kan benyttes ved behandling av klusterhodepiner
DE60206512D1 (de) Rapanycin29-enole
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
ATE514430T1 (de) Behandlung des alpha-galactosidase a mangels
HRP20020593B1 (en) Brain, spinal and nerve injury treatment
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
NO20034056D0 (no) Proliferative sykdommer
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
HUP0100586A2 (hu) Alsó húgyvezetéki tünetek kezelésére alkalmas gyógyászati készítmények
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
GB9902555D0 (en) Medicament
HUP0104688A2 (hu) Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez
HUP0301991A2 (hu) IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére
NO20053903L (no) Nukleotidlipidesterderivater.
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
HUP9904408A2 (hu) Lactobacillus vakcina prosztatagyulladás és jóindulatú prostatahyperplasia kezelésére
RS92304A (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for long-term preservation of acute urinary retention
EA200400197A1 (ru) Способы получения поливалентных бактериофагов для лечения бактериальных инфекций
HUP0401091A2 (hu) Atazanavir alkalmazása HIV-terápiában
NO20030137D0 (no) Fremgangsmåte for behandling av ustabil angina pectoris
EA200401100A1 (ru) 1α-ФТОР-25-ГИДРОКСИ-16,23E-ДИЕН-26,27-БИСГОМО-20-ЭПИХОЛЕКАЛЬЦИФЕРОЛ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ